Method of treating tumors with anti-tumor effective camptothecin

Details Method of treating tumors with anti-tumor effective camptothecin Method of treating tumors with anti-tumor effective camptothecin

1992-06-17

1994-08-23

Daus, Donald G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514253, 514283, A61K 3144

Patent

active

053408179

ABSTRACT:
A camptothecin analog having the structure shown below: ##STR1## where Z is H or C.sub.1-8 alkyl and R is NO.sub.2, NH.sub.2, N.sub.3, hydrogen, halogen, COOH, OH, O-C.sub.1-3 alkyl, SH, S-C.sub.1-3 alkyl, CN, CH.sub.2 NH.sub.2, NH-C.sub.1-3 alkyl, CH.sub.2 -NH-C.sub.1-3 alkyl, N(C.sub.1-3 alkyl).sub.2, CH.sub.2 N(C.sub.1-3 alkyl).sub.2, O-, NH- or S-CH.sub.2 CH.sub.2 N(CH.sub.2 CH.sub.2 OH).sub.2, O-, NH- or S- CH.sub.2 CH.sub.2 CH.sub.2 N(CH.sub.2 CH.sub.2 OH).sub.2, O-, NH- or S-CH.sub.2 CH.sub.2 N(CH.sub.2 CH.sub.2 CH.sub.2 OH).sub.2, O-, NH- or S-CH.sub.2 CH.sub.2 CH.sub.2 N(CH.sub.2 CH.sub.2 OH.sub.2).sub.2, O-, NH- or S-CH.sub.2 CH.sub.2 N(C.sub.1-3 alkyl).sub.2, O-, NH- or S-CH.sub.2 CH.sub.2 CH.sub.2 N(C.sub.1-3 alkyl).sub.2, CHO, C.sub.1-3 alkyl or NHCOCHR.sup.1 NR.sup.2 R.sup.3, where R.sup.1 is the side-chain of an .alpha.-amino acid and R.sup.2 and R.sup.3, independently are hydrogen or a lower alkyl group or R.sup.3 is a peptide unit containing 1-3 amino acid units bonded to the nitrogen through a peptide bond; NHCO-C.sub.2-8 -alkylene-X or NHCO-C.sub.2-8 -alkenylene-X, where X is COOH; CONR.sup.2 -(CH.sub.2).sub.n -NR.sup.2 R.sup.3, where n=1-10 and R.sup.2 and R.sup.3 are as defined above; NHCO-B-(CH.sub.2).sub.n-NR.sup.2 R.sup.3, where B=oxygen or NH, or ##STR2## where m+y=3-6, and salts thereof. The campothecin compounds inhibit the enzyme topisomerase I and are useful in treating tumors and leukemia.

REFERENCES:
patent: 4031098 (1977-06-01), Sugasawa
patent: 4473692 (1984-09-01), Miyasaka et al.
patent: 4545880 (1985-10-01), Miyasaka et al.
patent: 4604463 (1986-08-01), Miyasaka et al.
patent: 4894456 (1990-01-01), Wall et al.
patent: 4914205 (1990-04-01), Sawada et al.
patent: 4943579 (1990-07-01), Vishnuvajjala et al.
patent: 4981968 (1991-01-01), Wall et al.
patent: 5049668 (1991-09-01), Wall et al.
patent: 5053512 (1991-10-01), Wani et al.
patent: 5106742 (1992-04-01), Wall et al.
patent: 5122526 (1992-06-01), Wall et al.
patent: 5122606 (1992-06-01), Wani et al.
patent: 5180722 (1993-01-01), Wall et al.
patent: 5225404 (1993-07-01), Giovannella et al.
Mekhail-Ishak et al. Cancer Res. vol. 49 pp. 4866-4869 (1989).
Ferguson et al. Cancer Res vol. 49 pp. 1148-1153 (1989).
Davis Cancer vol. 50 pp. 2638-2646 (1982).
Yang, et al. (AR13), Chemical Abstracts, vol. 100: 139434w (1984).
Pan, et al., (AR14), Chemical Abstracts, vol. 84: 115629p (1976).
Wani, et al, J. Med. Chem., vol. 29, No. 11, pp. 2358-2363 (1986).
Wall, et al., J. Am. Chem. Soc., vol. 88, No. 16, pp. 3888-3890 (1966).
Cancer Research, (1989), vol. 49, 4385-5489, "DNA Topoisomerase I-Meditated DNA Cleavage and Cytotixicity of Camptothecin Analogues", Hisang et al.
Cancer Research, (1989), vol. 49, 1465-1469, "Structure-Activity Study of the Actions of Comptohecin Derivatives on Mammalian Topoisomerase I . . . "Jaxel et al.
The Journal of Biological Chemistry, (1985) 260, 14873-14878, "Camptothecin Induces Protein-Linked DNA Breaks Via Mammalian DNA Topoisomerase I" Hsiang et al.
J. Med. Chem, (1980), 23, 544-560, "Plant Antitumor Agents. 18. Synthesis and Bilogical Activity of Camptothecin Analogues", Wani et al.
J. Med. Chem, (1986), 29, 1553-1555, "Plant Antitumor Agents 22..sup.1 Isolation of 11-Hydroxycamptothecin From Camptotheca acuminata Decne . . . " Wall et al.
Journal of Labelled Compounds and Radiopharmaceuticals, (1981), 18, 319-329, "The Preparation of Tritium and Deuterium-Labelled Camptothecin", Ronman et al.
J. Medicinal Chemistry, (1987), 30, 1774-1779, "Plant Antitumor Agents 25..sup.1 Total Synthesis and Antileukemic Activity of Ring A . . .", Wani et al.
J. Medicinal Chemistry, (1990), 33, 972-978, "Plant Antitumor Agents. 29..sup.1 Synthesis and Biological Activity of Ring D and Ring 3 . . . " Nicholas et al.
J. Org. Chem. (1974), 39, 303-311, "Synthesis of Some DE and CDE Ring Analogs of Camptothecin", Plattner et al.
J. of Am. Chem. Soc. (1972), 94, 8615, "Synthesis of Some DE and CDE Ring Analogs of Camptothecin" Plattner et al.
J. Org. Chem., (1974), 39, 3430-3432, "Synthesis of Biological Evaluation of De-Ab-Camptothecin", Danishefsky et al.
Proc Annu. Meet. Am Assoc. Cancer Res, (1988), 29, A1080, "Structure-Activity Study of the Relation Between Topoisomerase I Inhibition and Antitumor . . . " Abstract.
Proc. Annu. Meet. Am Assoc. Cancer Res. (1989), 8, A1019, "A Clinical Study of a Camptothecin Derivative, CPT-11 on Hematological Malignancies", (Mtg Abstract).
Proc. Ann. Meet. Am Assoc. Cancer Res, (1989), 30, A2485, "Irreversible Trapping of the DNA-Topoisomerase I Covalent Complex and Affinity Labeling of . . . " Abstract.
J. Med. Chem, (1989), 32, 715-720, "Modification of the Hydroxy Lactone Ring of Camptothecin: Inhibition of Mammalian Topoisomerase I and . . . ", Mong et al Abstract.
Science, (1989), 246, 1046-1048, "DNA Topoisomerase I-Targeted Chemotherapy of Human Colon Cancer in Xenografts", Giovanella et al.
Proc. Annu. Meet. Am. Assoc. Cancer Res., (1989), A2476, "Structure-Activity Studies of 20(S)-Captothecin Analogs " (Meeting Abstract).
Yakult Honsha Co., Ltd., Antitumor Formulations Containing Camptothecin Derivatives; Chem Abstr 97:188278b (1982).
Smithkline Beckman Corp., New Water-Soluble Camptothecin Analogues-Are Useful as Antitumour Agents; EP 321-122A. Jun. 21, 1989 CA 89-179979/25.
Yaw-Huei Hsiang et al, Structure-Activity Studies of 20(S)-Camptothecin Analogs; (Meeting Abstract), Proc. Annu. Meet. Am. Assoc. Cancer Res., C565134 ICDB/89053589 (1989).
T. R. Govindachari et al, 9-Methoxycamptothecin. A New Alkaloid from Mappia foetida Miers; pp. 453-453 (1972).
Yakult Honsha Co., Ltd. Chem. Abstr. vol. 101:130677r (1984).
RP Hertzberg et al, Modification of the Hydroxy Lactone Ring of Camptothecin; Inhibition of Mammalian Topoisomerase I and Biological Activity; J. Med. Chem., vol. 32, No. 3, pp. 715-720, (1989).
RP Hertzberg et al, Irreversible Trapping of the DNA-Topoisomerase I Covalent Complex and Affinity Labeling of the Camptothecin Binding Site with 10-Bromoacetamidomethylcamptothecin (Meeting Abstract); Proc. Annu. Meet. Am. Assoc. Cancer Res.; 0651687 ICDB/89053598 (1989).
R. Ohno et al, A Clinical Study of a Camptothecin Derivative, CPT-11, On Hematological Malignancies (Meeting Abstract); Proc. Annu. Meet. Am. Soc. Clin. Oncol.; 0665698 ICDB/89054818 (1989).

Affiliated with

Also associated with

Rating

Method of treating tumors with anti-tumor effective camptothecin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating tumors with anti-tumor effective camptothecin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating tumors with anti-tumor effective camptothecin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-503241